Skip to main content

Arrhythmias During Pregnancy and Postpartum

  • Chapter
  • First Online:
Management of Cardiac Arrhythmias

Part of the book series: Contemporary Cardiology ((CONCARD))

Abstract

The incidence of cardiac arrhythmias during pregnancy is increasing, and the distribution of presenting arrhythmias is changing with an evolving maternal population. Atrial fibrillation is now the most common arrhythmia in pregnancy, but all types of arrhythmia and structural heart disease may be encountered. These arrhythmias may be associated with worse maternal and fetal outcomes. There are minimal data to guide management and decision-making in this patient population, and therapy should be reserved for those with severe symptoms. Diagnostic and therapeutic interventions should be avoided, if possible, during the first trimester. Antiarrhythmic drugs with the longest safety record should be used first. In the case of refractory arrhythmias, catheter ablation and device therapy can be performed utilizing techniques to minimize ionizing radiation.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 159.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Siu SC, Sermer M, Colman JM, Alvarez AN, Mercier LA, Morton BC, et al. Prospective multicenter study of pregnancy outcomes in women with heart disease. Circulation. 2001;104(5):515–21.

    CAS  PubMed  Google Scholar 

  2. Vaidya VR, Arora S, Patel N, Badheka AO, Patel N, Agnihotri K, et al. Burden of arrhythmia in pregnancy. Circulation. 2017;135(6):619–21.

    PubMed  Google Scholar 

  3. Lee SH, Chen SA, Wu TJ, Chiang CE, Cheng CC, Tai CT, et al. Effects of pregnancy on first onset and symptoms of paroxysmal supraventricular tachycardia. Am J Cardiol. 1995;76(10):675–8.

    CAS  PubMed  Google Scholar 

  4. Halpern DG, Weinberg CR, Pinnelas R, Mehta-Lee S, Economy KE, Valente AM. Use of medication for cardiovascular disease during pregnancy: JACC state-of-the-art review. J Am Coll Cardiol. 2019;73(4):457–76.

    PubMed  Google Scholar 

  5. Enriquez AD, Economy KE, Tedrow UB. Contemporary management of arrhythmias during pregnancy. Circ Arrhythm Electrophysiol. 2014;7(5):961–7.

    PubMed  Google Scholar 

  6. Franz MR, Cima R, Wang D, Profitt D, Kurz R. Electrophysiological effects of myocardial stretch and mechanical determinants of stretch-activated arrhythmias. Circulation. 1992;86(3):968–78.

    CAS  PubMed  Google Scholar 

  7. Ninio DM, Saint DA. The role of stretch-activated channels in atrial fibrillation and the impact of intracellular acidosis. Prog Biophys Mol Biol. 2008;97(2–3):401–16.

    CAS  PubMed  Google Scholar 

  8. Soliman EZ, Elsalam MA, Li Y. The relationship between high resting heart rate and ventricular arrhythmogenesis in patients referred to ambulatory 24 h electrocardiographic recording. Europace. 2010;12(2):261–5.

    PubMed  Google Scholar 

  9. Odening KE, Choi BR, Liu GX, Hartmann K, Ziv O, Chaves L, et al. Estradiol promotes sudden cardiac death in transgenic long QT type 2 rabbits while progesterone is protective. Heart Rhythm. 2012;9(5):823–32.

    PubMed  PubMed Central  Google Scholar 

  10. Makhija A, Sharada K, Hygriv Rao B, Thachil A, Narsimhan C. Hormone sensitive idiopathic ventricular tachycardia associated with pregnancy: successful induction with progesterone and radiofrequency ablation. J Cardiovasc Electrophysiol. 2011;22(1):95–8.

    PubMed  Google Scholar 

  11. Roberts JM, Insel PA, Goldfien A. Regulation of myometrial adrenoreceptors and adrenergic response by sex steroids. Mol Pharmacol. 1981;20(1):52–8.

    CAS  PubMed  Google Scholar 

  12. Barron WM, Mujais SK, Zinaman M, Bravo EL, Lindheimer MD. Plasma catecholamine responses to physiologic stimuli in normal human pregnancy. Am J Obstet Gynecol. 1986;154(1):80–4.

    CAS  PubMed  Google Scholar 

  13. Anneken L, Baumann S, Vigneault P, Biliczki P, Friedrich C, Xiao L, et al. Estradiol regulates human QT-interval: acceleration of cardiac repolarization by enhanced KCNH2 membrane trafficking. Eur Heart J. 2016;37(7):640–50.

    CAS  PubMed  Google Scholar 

  14. Shotan A, Ostrzega E, Mehra A, Johnson JV, Elkayam U. Incidence of arrhythmias in normal pregnancy and relation to palpitations, dizziness, and syncope. Am J Cardiol. 1997;79(8):1061–4.

    CAS  PubMed  Google Scholar 

  15. Li JM, Nguyen C, Joglar JA, Hamdan MH, Page RL. Frequency and outcome of arrhythmias complicating admission during pregnancy: experience from a high-volume and ethnically-diverse obstetric service. Clin Cardiol. 2008;31(11):538–41.

    PubMed  PubMed Central  Google Scholar 

  16. Martin JAHB, Osterman MJK, Driscoll AK, Drake P. Births: final data for 2016. Natl Vital Stat Rep. 2018;67(1):1–55.

    PubMed  Google Scholar 

  17. Silversides CK, Grewal J, Mason J, Sermer M, Kiess M, Rychel V, et al. Pregnancy outcomes in women with heart disease: the CARPREG II study. J Am Coll Cardiol. 2018;71(21):2419–30.

    PubMed  Google Scholar 

  18. Patel SJ, Reede DL, Katz DS, Subramaniam R, Amorosa JK. Imaging the pregnant patient for nonobstetric conditions: algorithms and radiation dose considerations. Radiographics. 2007;27(6):1705–22.

    PubMed  Google Scholar 

  19. Best PJ, Skelding KA, Mehran R, Chieffo A, Kunadian V, Madan M, et al. SCAI consensus document on occupational radiation exposure to the pregnant cardiologist and technical personnel. Catheter Cardiovasc Interv. 2011;77(2):232–41.

    PubMed  Google Scholar 

  20. Brucker MC, King TL. The 2015 US food and drug administration pregnancy and lactation labeling rule. J Midwifery Womens Health. 2017;62(3):308–16.

    PubMed  Google Scholar 

  21. Joglar JA, Page RL. Treatment of cardiac arrhythmias during pregnancy: safety considerations. Drug Saf. 1999;20(1):85–94.

    CAS  PubMed  Google Scholar 

  22. Cox JL, Gardner MJ. Treatment of cardiac arrhythmias during pregnancy. Prog Cardiovasc Dis. 1993;36(2):137–78.

    CAS  PubMed  Google Scholar 

  23. Meyer JLJ, Schochnet S. Paroxysmal tachycardia in pregnancy. Am Heart J. 1931;94:1901–4.

    Google Scholar 

  24. Hill LM, Malkasian GD Jr. The use of quinidine sulfate throughout pregnancy. Obstet Gynecol. 1979;54(3):366–8.

    CAS  PubMed  Google Scholar 

  25. Chow T, Galvin J, McGovern B. Antiarrhythmic drug therapy in pregnancy and lactation. Am J Cardiol. 1998;82(4A):58I–62I.

    CAS  PubMed  Google Scholar 

  26. Allen NM, Page RL. Procainamide administration during pregnancy. Clin Pharm. 1993;12(1):58–60.

    CAS  PubMed  Google Scholar 

  27. Page RL. Treatment of arrhythmias during pregnancy. Am Heart J. 1995;130(4):871–6.

    CAS  PubMed  Google Scholar 

  28. Leonard RF, Braun TE, Levy AM. Initiation of uterine contractions by disopyramide during pregnancy. N Engl J Med. 1978;299(2):84–5.

    CAS  PubMed  Google Scholar 

  29. Gregg AR, Tomich PG. Mexilitene use in pregnancy. J Perinatol. 1988;8(1):33–5.

    CAS  PubMed  Google Scholar 

  30. Ahmed K, Issawi I, Peddireddy R. Use of flecainide for refractory atrial tachycardia of pregnancy. Am J Crit Care. 1996;5(4):306–8.

    CAS  PubMed  Google Scholar 

  31. Jaeggi ET, Carvalho JS, De Groot E, Api O, Clur SA, Rammeloo L, et al. Comparison of transplacental treatment of fetal supraventricular tachyarrhythmias with digoxin, flecainide, and sotalol: results of a nonrandomized multicenter study. Circulation. 2011;124(16):1747–54.

    CAS  PubMed  Google Scholar 

  32. Allan LD, Chita SK, Sharland GK, Maxwell D, Priestley K. Flecainide in the treatment of fetal tachycardias. Br Heart J. 1991;65(1):46–8.

    CAS  PubMed  PubMed Central  Google Scholar 

  33. Capucci A, Boriani G. Propafenone in the treatment of cardiac arrhythmias. A risk-benefit appraisal. Drug Saf. 1995;12(1):55–72.

    CAS  PubMed  Google Scholar 

  34. Echt DS, Liebson PR, Mitchell LB, Peters RW, Obias-Manno D, Barker AH, et al. Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The cardiac arrhythmia suppression trial. N Engl J Med. 1991;324(12):781–8.

    CAS  PubMed  Google Scholar 

  35. Frishman WH, Chesner M. Beta-adrenergic blockers in pregnancy. Am Heart J. 1988;115(1 Pt 1):147–52.

    CAS  PubMed  Google Scholar 

  36. Lip GY, Beevers M, Churchill D, Shaffer LM, Beevers DG. Effect of atenolol on birth weight. Am J Cardiol. 1997;79(10):1436–8.

    CAS  PubMed  Google Scholar 

  37. Wichman K, Ryden G, Karlberg BE. A placebo controlled trial of metoprolol in the treatment of hypertension in pregnancy. Scand J Clin Lab Invest Suppl. 1984;169:90–5.

    CAS  PubMed  Google Scholar 

  38. Widerhorn J, Bhandari AK, Bughi S, Rahimtoola SH, Elkayam U. Fetal and neonatal adverse effects profile of amiodarone treatment during pregnancy. Am Heart J. 1991;122(4 Pt 1):1162–6.

    CAS  PubMed  Google Scholar 

  39. Ovadia M, Brito M, Hoyer GL, Marcus FI. Human experience with amiodarone in the embryonic period. Am J Cardiol. 1994;73(4):316–7.

    CAS  PubMed  Google Scholar 

  40. Kozlowski D, Budrejko S, Lip GY, Mikhailidis DP, Rysz J, Raczak G, et al. Dronedarone: an overview. Ann Med. 2012;44(1):60–72.

    CAS  PubMed  Google Scholar 

  41. O’Hare MF, Murnaghan GA, Russell CJ, Leahey WJ, Varma MP, McDevitt DG. Sotalol as a hypotensive agent in pregnancy. Br J Obstet Gynaecol. 1980;87(9):814–20.

    PubMed  Google Scholar 

  42. Wagner X, Jouglard J, Moulin M, Miller AM, Petitjean J, Pisapia A. Coadministration of flecainide acetate and sotalol during pregnancy: lack of teratogenic effects, passage across the placenta, and excretion in human breast milk. Am Heart J. 1990;119(3 Pt 1):700–2.

    CAS  PubMed  Google Scholar 

  43. Ritchie HE, Ababneh DH, Oakes DJ, Power CA, Webster WS. The teratogenic effect of dofetilide during rat limb development and association with drug-induced bradycardia and hypoxia in the embryo. Birth Defects Res B Dev Reprod Toxicol. 2013;98(2):144–53.

    CAS  PubMed  Google Scholar 

  44. Marks TA, Terry RD. Developmental toxicity of ibutilide fumarate in rats after oral administration. Teratology. 1996;54(3):157–64.

    CAS  PubMed  Google Scholar 

  45. Burkart TA, Kron J, Miles WM, Conti JB, Gonzalez MD. Successful termination of atrial flutter by ibutilide during pregnancy. Pacing Clin Electrophysiol. 2007;30(2):283–6.

    PubMed  Google Scholar 

  46. Kockova R, Kocka V, Kiernan T, Fahy GJ. Ibutilide-induced cardioversion of atrial fibrillation during pregnancy. J Cardiovasc Electrophysiol. 2007;18(5):545–7.

    PubMed  Google Scholar 

  47. Byerly WG, Hartmann A, Foster DE, Tannenbaum AK. Verapamil in the treatment of maternal paroxysmal supraventricular tachycardia. Ann Emerg Med. 1991;20(5):552–4.

    CAS  PubMed  Google Scholar 

  48. Joglar JA, Page RL. Management of arrhythmia syndromes during pregnancy. Curr Opin Cardiol. 2014;29(1):36–44.

    PubMed  Google Scholar 

  49. Gonzalez AR, Phelps SJ, Cochran EB, Sibai BM. Digoxin-like immunoreactive substance in pregnancy. Am J Obstet Gynecol. 1987;157(3):660–4.

    CAS  PubMed  Google Scholar 

  50. Jaqueti J, Martinez-Hernandez D, Hernandez-Garcia R, Navarro-Gallar F, Arenas-Barbero J. Adenosine deaminase in pregnancy serum. Clin Chem. 1990;36(12):2144.

    CAS  PubMed  Google Scholar 

  51. Wang YC, Chen CH, Su HY, Yu MH. The impact of maternal cardioversion on fetal haemodynamics. Eur J Obstet Gynecol Reprod Biol. 2006;126(2):268–9.

    PubMed  Google Scholar 

  52. Barnes EJ, Eben F, Patterson D. Direct current cardioversion during pregnancy should be performed with facilities available for fetal monitoring and emergency caesarean section. BJOG. 2002;109(12):1406–7.

    PubMed  Google Scholar 

  53. Damilakis J, Theocharopoulos N, Perisinakis K, Manios E, Dimitriou P, Vardas P, et al. Conceptus radiation dose and risk from cardiac catheter ablation procedures. Circulation. 2001;104(8):893–7.

    CAS  PubMed  Google Scholar 

  54. Kanjwal Y, Kosinski D, Kanj M, Thomas W, Grubb B. Successful radiofrequency catheter ablation of left lateral accessory pathway using transseptal approach during pregnancy. J Interv Card Electrophysiol. 2005;13(3):239–42.

    PubMed  Google Scholar 

  55. Berruezo A, Diez GR, Berne P, Esteban M, Mont L, Brugada J. Low exposure radiation with conventional guided radiofrequency catheter ablation in pregnant women. Pacing Clin Electrophysiol. 2007;30(10):1299–302.

    PubMed  Google Scholar 

  56. Szumowski L, Szufladowicz E, Orczykowski M, Bodalski R, Derejko P, Przybylski A, et al. Ablation of severe drug-resistant tachyarrhythmia during pregnancy. J Cardiovasc Electrophysiol. 2010;21(8):877–82.

    PubMed  Google Scholar 

  57. Ferguson JD, Helms A, Mangrum JM, DiMarco JP. Ablation of incessant left atrial tachycardia without fluoroscopy in a pregnant woman. J Cardiovasc Electrophysiol. 2011;22(3):346–9.

    PubMed  Google Scholar 

  58. Bongiorni MG, Di Cori A, Soldati E, Zucchelli G, Segreti L, Solarino G, et al. Radiofrequency catheter ablation of atrioventricular nodal reciprocating tachycardia using intracardiac echocardiography in pregnancy. Europace. 2008;10(8):1018–21.

    PubMed  Google Scholar 

  59. Lee MS, Evans SJ, Blumberg S, Bodenheimer MM, Roth SL. Echocardiographically guided electrophysiologic testing in pregnancy. J Am Soc Echocardiogr. 1994;7(2):182–6.

    CAS  PubMed  Google Scholar 

  60. Razminia M, Willoughby MC, Demo H, Keshmiri H, Wang T, D’Silva OJ, et al. Fluoroless catheter ablation of cardiac arrhythmias: a 5-year experience. Pacing Clin Electrophysiol. 2017;40(4):425–33.

    PubMed  Google Scholar 

  61. Kozluk E, Piatkowska A, Kiliszek M, Lodzinski P, Malkowska S, Balsam P, et al. Catheter ablation of cardiac arrhythmias in pregnancy without fluoroscopy: a case control retrospective study. Adv Clin Exp Med. 2017;26(1):129–34.

    PubMed  Google Scholar 

  62. Blomstrom-Lundqvist C, Scheinman MM, Aliot EM, Alpert JS, Calkins H, Camm AJ, et al. ACC/AHA/ESC guidelines for the management of patients with supraventricular arrhythmias--executive summary. Circulation. 2003;108(15):1871–909.

    PubMed  Google Scholar 

  63. Tawam M, Levine J, Mendelson M, Goldberger J, Dyer A, Kadish A. Effect of pregnancy on paroxysmal supraventricular tachycardia. Am J Cardiol. 1993;72(11):838–40.

    CAS  PubMed  Google Scholar 

  64. Chang SH, Kuo CF, Chou IJ, See LC, Yu KH, Luo SF, et al. Outcomes associated with paroxysmal supraventricular tachycardia during pregnancy. Circulation. 2017;135(6):616–8.

    PubMed  Google Scholar 

  65. Peleg D, Orvieto R, Ferber A, Ben-Rafael Z. Maternal supraventricular tachycardia recorded as apparent fetal heart rate in a case of fetal demise. Acta Obstet Gynecol Scand. 1998;77(7):786–7.

    CAS  PubMed  Google Scholar 

  66. Smith WM, Gallagher JJ, Kerr CR, Sealy WC, Kasell JH, Benson DW Jr, et al. The electrophysiologic basis and management of symptomatic recurrent tachycardia in patients with Ebstein’s anomaly of the tricuspid valve. Am J Cardiol. 1982;49(5):1223–34.

    CAS  PubMed  Google Scholar 

  67. Page RL, Joglar JA, Caldwell MA, Calkins H, Conti JB, Deal BJ, et al. 2015 ACC/AHA/HRS guideline for the management of adult patients with supraventricular tachycardia: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2016;67(13):e27–e115.

    PubMed  Google Scholar 

  68. Appelboam A, Reuben A, Mann C, Gagg J, Ewings P, Barton A, et al. Postural modification to the standard Valsalva manoeuvre for emergency treatment of supraventricular tachycardias (REVERT): a randomised controlled trial. Lancet. 2015;386(10005):1747–53.

    PubMed  Google Scholar 

  69. Elkayam U, Goodwin TM. Adenosine therapy for supraventricular tachycardia during pregnancy. Am J Cardiol. 1995;75(7):521–3.

    CAS  PubMed  Google Scholar 

  70. Gleicher N, Meller J, Sandler RZ, Sullum S. Wolff-Parkinson-White syndrome in pregnancy. Obstet Gynecol. 1981;58(6):748–52.

    CAS  PubMed  Google Scholar 

  71. Regitz-Zagrosek V, Roos-Hesselink JW, Bauersachs J, Blomstrom-Lundqvist C, Cifkova R, De Bonis M, et al. 2018 ESC guidelines for the management of cardiovascular diseases during pregnancy. Eur Heart J. 2018;39(34):3165–241.

    PubMed  Google Scholar 

  72. Doig JC, McComb JM, Reid DS. Incessant atrial tachycardia accelerated by pregnancy. Br Heart J. 1992;67(3):266–8.

    CAS  PubMed  PubMed Central  Google Scholar 

  73. Schroeder JS, Harrison DC. Repeated cardioversion during pregnancy. Treatment of refractory paroxysmal atrial tachycardia during 3 successive pregnancies. Am J Cardiol. 1971;27(4):445–6.

    CAS  PubMed  Google Scholar 

  74. Camm AJ, Kirchhof P, Lip GY, Schotten U, Savelieva I, Ernst S, et al. Guidelines for the management of atrial fibrillation: the task force for the management of atrial fibrillation of the European Society of Cardiology (ESC). Europace. 2010;12(10):1360–420.

    PubMed  Google Scholar 

  75. January CT, Wann LS, Calkins H, Chen LY, Cigarroa JE, Cleveland JC Jr, et al. 2019 AHA/ACC/HRS focused update of the 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2019;74(1):104–32.

    Google Scholar 

  76. Beyer-Westendorf J, Michalski F, Tittl L, Middeldorp S, Cohen H, Abdul Kadir R, et al. Pregnancy outcome in patients exposed to direct oral anticoagulants – and the challenge of event reporting. Thromb Haemost. 2016;116(4):651–8.

    PubMed  Google Scholar 

  77. Silversides CK, Harris L, Haberer K, Sermer M, Colman JM, Siu SC. Recurrence rates of arrhythmias during pregnancy in women with previous tachyarrhythmia and impact on fetal and neonatal outcomes. Am J Cardiol. 2006;97(8):1206–12.

    PubMed  Google Scholar 

  78. Autore C, Conte MR, Piccininno M, Bernabo P, Bonfiglio G, Bruzzi P, et al. Risk associated with pregnancy in hypertrophic cardiomyopathy. J Am Coll Cardiol. 2002;40(10):1864–9.

    PubMed  Google Scholar 

  79. Bauce B, Daliento L, Frigo G, Russo G, Nava A. Pregnancy in women with arrhythmogenic right ventricular cardiomyopathy/dysplasia. Eur J Obstet Gynecol Reprod Biol. 2006;127(2):186–9.

    PubMed  Google Scholar 

  80. Hankins GD, Wendel GD Jr, Leveno KJ, Stoneham J. Myocardial infarction during pregnancy: a review. Obstet Gynecol. 1985;65(1):139–46.

    CAS  PubMed  Google Scholar 

  81. Ertekin E, van Hagen IM, Salam AM, Ruys TP, Johnson MR, Popelova J, et al. Ventricular tachyarrhythmia during pregnancy in women with heart disease: data from the ROPAC, a registry from the European Society of Cardiology. Int J Cardiol. 2016;220:131–6.

    PubMed  Google Scholar 

  82. Puri A, Sethi R, Singh B, Dwivedi S, Narain V, Saran R, et al. Peripartum cardiomyopathy presenting with ventricular tachycardia: a rare presentation. Indian Pacing Electrophysiol J. 2009;9(3):186–9.

    CAS  PubMed  PubMed Central  Google Scholar 

  83. Al-Khatib SM, Stevenson WG, Ackerman MJ, Bryant WJ, Callans DJ, Curtis AB, et al. 2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2018;72(14):e91–e220.

    PubMed  Google Scholar 

  84. Zipes DP, Camm AJ, Borggrefe M, Buxton AE, Chaitman B, Fromer M, et al. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Circulation. 2006;114(10):e385–484.

    PubMed  Google Scholar 

  85. Stec S, Krynski T, Baran J, Kulakowski P. “Rescue” ablation of electrical storm in arrhythmogenic right ventricular cardiomyopathy in pregnancy. BMC Cardiovasc Disord. 2013;13:58.

    PubMed  PubMed Central  Google Scholar 

  86. Abello M, Peinado R, Merino JL, Gnoatto M, Mateos M, Silvestre J, et al. Cardioverter defibrillator implantation in a pregnant woman guided with transesophageal echocardiography. Pacing Clin Electrophysiol. 2003;26(9):1913–4.

    PubMed  Google Scholar 

  87. Tuzcu V, Kilinc OU. Implantable cardioverter defibrillator implantation without using fluoroscopy in a pregnant patient. Pacing Clin Electrophysiol. 2012;35(9):e265–6.

    PubMed  Google Scholar 

  88. Saltzberg MT, Szymkiewicz S, Bianco NR. Characteristics and outcomes of peripartum versus nonperipartum cardiomyopathy in women using a wearable cardiac defibrillator. J Card Fail. 2012;18(1):21–7.

    PubMed  Google Scholar 

  89. Natale A, Davidson T, Geiger MJ, Newby K. Implantable cardioverter-defibrillators and pregnancy: a safe combination? Circulation. 1997;96(9):2808–12.

    CAS  PubMed  Google Scholar 

  90. Lemery R, Brugada P, Bella PD, Dugernier T, van den Dool A, Wellens HJ. Nonischemic ventricular tachycardia. Clinical course and long-term follow-up in patients without clinically overt heart disease. Circulation. 1989;79(5):990–9.

    CAS  PubMed  Google Scholar 

  91. Brodsky M, Doria R, Allen B, Sato D, Thomas G, Sada M. New-onset ventricular tachycardia during pregnancy. Am Heart J. 1992;123(4 Pt 1):933–41.

    CAS  PubMed  Google Scholar 

  92. Chandra NC, Gates EA, Thamer M. Conservative treatment of paroxysmal ventricular tachycardia during pregnancy. Clin Cardiol. 1991;14(4):347–50.

    CAS  PubMed  Google Scholar 

  93. Cleary-Goldman J, Salva CR, Infeld JI, Robinson JN. Verapamil-sensitive idiopathic left ventricular tachycardia in pregnancy. J Matern Fetal Neonatal Med. 2003;14(2):132–5.

    CAS  PubMed  Google Scholar 

  94. Chen G, Sun G, Xu R, Chen X, Yang L, Bai Y, et al. Zero-fluoroscopy catheter ablation of severe drug-resistant arrhythmia guided by Ensite NavX system during pregnancy: two case reports and literature review. Medicine (Baltimore). 2016;95(32):e4487.

    Google Scholar 

  95. Hogarth AJ, Graham LN. Normal heart ventricular tachycardia associated with pregnancy: successful treatment with catheter ablation. Indian Pacing Electrophysiol J. 2014;14(2):79–82.

    PubMed  PubMed Central  Google Scholar 

  96. Rashba EJ, Zareba W, Moss AJ, Hall WJ, Robinson J, Locati EH, et al. Influence of pregnancy on the risk for cardiac events in patients with hereditary long QT syndrome. LQTS Invest Circ. 1998;97(5):451–6.

    CAS  Google Scholar 

  97. Seth R, Moss AJ, McNitt S, Zareba W, Andrews ML, Qi M, et al. Long QT syndrome and pregnancy. J Am Coll Cardiol. 2007;49(10):1092–8.

    PubMed  Google Scholar 

  98. Ishibashi K, Aiba T, Kamiya C, Miyazaki A, Sakaguchi H, Wada M, et al. Arrhythmia risk and beta-blocker therapy in pregnant women with long QT syndrome. Heart. 2017;103(17):1374–9.

    PubMed  Google Scholar 

  99. Antonelli D, Bloch L, Rosenfeld T. Implantation of permanent dual chamber pacemaker in a pregnant woman by transesophageal echocardiographic guidance. Pacing Clin Electrophysiol. 1999;22(3):534–5.

    CAS  PubMed  Google Scholar 

  100. Dalvi BV, Chaudhuri A, Kulkarni HL, Kale PA. Therapeutic guidelines for congenital complete heart block presenting in pregnancy. Obstet Gynecol. 1992;79(5(Pt2)):802–4.

    CAS  PubMed  Google Scholar 

  101. Hidaka N, Chiba Y, Fukushima K, Wake N. Pregnant women with complete atrioventricular block: perinatal risks and review of management. Pacing Clin Electrophysiol. 2011;34(9):1161–76.

    PubMed  Google Scholar 

  102. Lipowicz AA, Cheskes S, Gray SH, Jeejeebhoy F, Lee J, Scales DC, et al. Incidence, outcomes and guideline compliance of out-of-hospital maternal cardiac arrest resuscitations: a population-based cohort study. Resuscitation. 2018;132:127–32.

    PubMed  Google Scholar 

  103. Drenthen W, Pieper PG, Roos-Hesselink JW, van Lottum WA, Voors AA, Mulder BJ, et al. Outcome of pregnancy in women with congenital heart disease: a literature review. J Am Coll Cardiol. 2007;49(24):2303–11.

    PubMed  Google Scholar 

  104. Fuster V, Harrington RA, Narula J, Eapen ZJ, editors. Hurst’s the heart. 14th ed. New York: McGraw Hill; 2017.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Usha B. Tedrow .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Enriquez, A.D., Tedrow, U.B. (2020). Arrhythmias During Pregnancy and Postpartum. In: Yan, GX., Kowey, P., Antzelevitch, C. (eds) Management of Cardiac Arrhythmias. Contemporary Cardiology. Humana, Cham. https://doi.org/10.1007/978-3-030-41967-7_28

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-41967-7_28

  • Published:

  • Publisher Name: Humana, Cham

  • Print ISBN: 978-3-030-41966-0

  • Online ISBN: 978-3-030-41967-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics